Mint Incorporation Limited

Fiscal years end March 31. USD millions unless stated. FY2023–FY2026 core lines come from the 20-F filings as normalised by MarketBeat/StockAnalysis (S&P Global). FY2022 is aggregator-only (StockAnalysis/VCP Scanner/ROIC.ai).

Income statement

Notes: - FY2026 net loss is exactly US$10,315,204 (20-F FY2026). FY2026 operating income is computed as gross profit less SG&A, selling and marketing, and R&D (MarketBeat shows "-10" rounded).

• FY2026 EPS of -4.15 is StockAnalysis (post-split). FY2022–FY2025 EPS are analyst derivations: aggregator pre-split EPS (≈0.01, 0.04, 0.03, -0.07) × 10 for the 1-for-10 split. They are approximations.

• FY2023 DPS is derived from the US$0.55M pre-IPO dividend ÷ ≈23M pre-split shares (ROIC.ai shows US$0.02 pre-split).

• EBITDA = operating income + D&A (D&A ≈0.05/0.00/0.04/0.06 for FY2022–FY2025). FY2026 D&A is not disclosed in the sources reviewed.

Source conflict: StockTitan reports FY2025 revenue of US$3.1M and a 23.8% gross margin. SEC-derived aggregators (financialfilings.com, MarketBeat, Simply Wall St) report US$3.27M and ≈22.2%. The latter agrees with the FY2026 20-F's 22.2% FY2025 margin and is used here.

Margins and growth

Revenue CAGR FY2022→FY2026: ≈+2.0% p.a. Revenue CAGR FY2024→FY2026: ≈-27.7% p.a. Group gross margin in FY2026 (10.9%) exceeds the interior segment's 7.4% because robotics product sales carried a higher margin, implied but not separately disclosed.

Commentary: income statement. The record has three phases.

1. Profitable small contractor (FY2022–FY2024). Revenue doubled from ≈US$2.1M to US$4.4M with net margins of 12–31%. The high-margin design-only line lifted gross margin to 47% in FY2023.

2. IPO-year inflection (FY2025). Revenue fell 25.5% as design-only work fell from ≈US$0.8M to ≈US$0.3M. SG&A jumped more than threefold to US$2.30M as listed-company costs arrived; executive salaries alone rose from ≈US$49K each to ≈US$514K each for the two founders. The company swung to a US$1.46M net loss.

3. Pivot year (FY2026). Revenue fell a further 29.9%. Interior gross margin collapsed to 7.4%, and US$7.82M of share-based compensation to consultants (2.4M pre-split shares under the 2025 Stock Incentive Plan) produced a US$10.3M net loss.

Excluding the non-cash SBC, the FY2026 underlying operating loss was roughly US$2.5M. That is still an operating cost base about equal to total revenue. Interim data confirm the deterioration: H1 FY2026 (six months to Sep 30, 2025) revenue was US$988K (-26.2% YoY), gross profit only US$43K (4.4% margin versus 34.5%), and net loss US$8.58M versus net income of US$132K a year earlier (6-K, H1 FY2026).

Balance sheet

Sources: StockAnalysis (S&P Global) for FY2022–FY2025. 20-F FY2026 for FY2026 cash (US$964,142) and equity (US$3,284,813). The August 2026 prospectus reports net tangible book value of US$0.610 per post-split share before the August offering and US$0.647 after it.

Commentary: balance sheet. IPO proceeds (≈US$6.05M net equity issuance) transformed a sub-US$1M balance sheet into a US$7.6M one at FY2025 year-end, with US$4.5M of cash. The group also took on ≈US$1.16M of long-term debt in FY2025. By FY2026 year-end cash had fallen to US$0.96M and equity to US$3.28M. Receivables are a growing share of assets: days sales outstanding rose from ≈50 days (FY2022) to ≈161 days (FY2025). That is a meaningful credit and liquidity exposure given the customer concentration. Post-balance-sheet, the company raised US$2.0M (July PIPE), US$2.0M (August PIPE) and ≈US$2.33M net (August registered direct offering), so pro-forma cash was replenished. From April 1 to late August 2026 the parent also pushed ≈US$2.24M to Matter International and Axonex Intelligence as intercompany funding (424B5).

Cash flow

Sources: StockAnalysis (S&P Global) for FY2022–FY2025. Benzinga trailing figures for FY2026 (OCF -858.39K, CFI -2.58M, CFF -103.79K, capex -205.05K, net change -3.54M). These reconcile with the drop in cash from US$4.52M to US$0.96M and are treated as FY2026. FY2026 investing outflows include the US$1.0M YAS Robotics capital contribution (Dec 15, 2025).

Commentary: cash flow. FY2025 operating cash burn (US$3.26M) was larger than the reported loss because of a ≈US$1.9M working-capital build, including ≈US$1.21M in other operating assets and prepayments. FY2026 OCF of about -US$0.86M is modest relative to the US$10.3M accounting loss, which confirms the loss was mostly non-cash SBC. Investing outflows of ≈US$2.6M in FY2026 reflect the pivot: JV contributions (US$1.0M to YAS) and an uptick in capex (≈US$0.2M). There have been no buybacks, and the only dividend (≈US$0.55M) was paid before the IPO in FY2023.

Ratios

Analyst computations from the tables above, using average equity and assets where two year-ends are available. ROIC is not meaningful: the company has negligible invested debt, and its large net-cash position in FY2025 distorts the metric. Net debt/EBITDA is not meaningful: net cash in FY2022–FY2025 and negative EBITDA in FY2025–FY2026. A cash conversion cycle cannot be computed because inventory and payables days are not consistently disclosed. FY2023 ROE is inflated by a very small equity base (US$0.14M → US$0.41M).

Trend synthesis. Pre-IPO returns on equity were exceptionally high because the business ran on a tiny equity base and paid out cash. Post-IPO, returns turned sharply negative as overhead expanded and revenue fell. The receivables trend (DSO tripling from FY2022 to FY2025) is the key operating red flag within the legacy business. Liquidity ratios peaked artificially in FY2025 on IPO cash and had deteriorated by FY2026.

Management guidance and consensus

Management guidance: none. No revenue, margin or profitability guidance has been issued. Qualitative commitments cover commercial release of FLOKI M1, overseas expansion (Southeast Asia, Japan, US) and completion of the Ascendze transaction.

Consensus expectations: none available (no analyst coverage).

Bull case

1. Robotics optionality on a small base. Robotics was already ≈17% of FY2026 revenue. Commercial launch of FLOKI M1 through Rice Robotics AGI (with an operating Japan entity), plus a Yunji co-developed cleaning robot, could make robotics the majority of revenue within one to two years on a base of only ≈US$2M.

2. Ascendze as a step-change. A controlling stake in a Singapore semiconductor-automation business with blue-chip customers (Fabrinet cited) could add revenue several times Mint's own and change the investment story, if financed without crippling dilution.

3. Core can return to profitability at scale. The fit-out business earned 18–31% net margins at US$2.7–4.4M revenue in FY2023–FY2024. Recurring customers recovered to 15 in FY2026, so restoring design-only mix could rebuild gross margin toward 20–35%.

Bear case

1. Structural decline plus cash dependence. Core revenue fell 41.6% and gross margin collapsed to 7.4%. FY2026 year-end cash was US$0.96M. Survival has depended on PIPEs priced at 20% of market, with the Class A share count up more than sevenfold in five months.

2. The pivot lacks substance. R&D is ≈US$0.13M, IP is shared with partners, one JV (STG) was abandoned within months, ownership of the key Rice JV is reported inconsistently (54% vs. 87.5%), and the largest proposed deal (Ascendze) is a non-binding MOU.

3. Listing and governance risk. The stock is again below US$1.00 within months of a reverse split. Nasdaq's tightened rules may deny a new compliance period. Combined with founder super-voting control and consultant share awards worth US$7.82M in one year, minority shareholders bear disproportionate risk.

Catalysts and monitorables (next 12 months)

Analyst verdict

Mint Incorporation is, on the evidence of its own filings, a very small Hong Kong interior-fit-out contractor that is using its Nasdaq listing to fund a rapid and loosely connected expansion into robotics, AI, insurance and possibly semiconductor automation.

The legacy business has real capabilities: a seven-year operating record, brand-name retail clients and historically healthy margins. But it is shrinking quickly. Revenue roughly halved from US$4.38M in FY2024 to US$2.29M in FY2026, and segment gross margin fell from 35.6% to 7.4%.

The robotics thesis has visible but early markers: a FLOKI M1 prototype, exhibition debuts, a Yunji development contract and ≈US$0.38M of product sales. Disclosed R&D, however, is minimal, and much of the technology sits with JV partners.

Financially, the FY2026 US$10.3M loss is mostly non-cash share compensation. That does not make it benign. It reflects an equity-funded operating model in which consultants and new PIPE investors were issued shares at deep discounts to market, while founders strengthened voting control through Class B shares. The roughly sevenfold expansion in Class A shares since March 2026, the return of the share price below US$1.00 within months of a reverse split, and repeated board turnover together form a pattern institutional investors would treat as a high-risk governance and dilution profile.

The investment case therefore rests almost entirely on execution events that have not yet happened: definitive terms for Ascendze, commercial sales of FLOKI M1 and the Yunji robot, and stabilisation of the fit-out core. Until audited results show robotics revenue scaling and cash burn financed on less dilutive terms, the risk-reward appears asymmetric to the downside. The equity behaves more as a speculative, liquidity-driven instrument than a fundamentally anchored security.

Analyst stance: high risk / speculative. Priority monitorables are Nasdaq listing status, the Ascendze deal terms and the H1 FY2027 cash position.